Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Galapagos NV
Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.
IPO Date: March 1, 2012
Sector: Healthcare
Industry: Biotech
Market Cap: $1.99B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.91 | 1.16%
Avg Daily Range (30 D): $0.30 | 1.02%
Avg Daily Range (90 D): $0.33 | 1.21%
Institutional Daily Volume
Avg Daily Volume: .16M
Avg Daily Volume (30 D): .23M
Avg Daily Volume (90 D): .3M
Trade Size
Avg Trade Size (Sh.): 75
Avg Trade Size (Sh.) (30 D): 64
Avg Trade Size (Sh.) (90 D): 65
Institutional Trades
Total Inst.Trades: 1,161
Avg Inst. Trade: $2.41M
Avg Inst. Trade (30 D): $1.25M
Avg Inst. Trade (90 D): $1.56M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.05M
Avg Closing Trade (30 D): $.98M
Avg Closing Trade (90 D): $.95M
Avg Closing Volume: 34.71K
   
News
Jun 23, 2025 @ 5:30 AM
Galapagos Appoints Aaron Cox as Chief Financial Of...
Source: N/A
Jun 23, 2025 @ 5:30 AM
Galapagos benoemt Aaron Cox als Chief Financial Of...
Source: N/A
Jun 5, 2025 @ 5:00 AM
Planisware expands into Belgium to support the sus...
Source: N/A
Apr 15, 2025 @ 5:30 AM
Galapagos kondigt het vertrek van haar CFO en COO,...
Source: N/A
Apr 15, 2025 @ 5:30 AM
Galapagos Announces Departure of Thad Huston, CFO ...
Source: N/A